White Paper: IST Feasibility Study
Feasibility study on improving cryopreservation of PBMC for more reliable information from clinical trials
Effective comparison of immune responses during the course of the trial depends greatly on the quantity and quality of the PBMC samples. To date, preservation of PBMC relies on laborious and time sensitive manual procedures to isolate, freeze, and thaw cells that make the process highly variable and dependant on the experience/skills of the collection and test sites. Therefore, this feasibility study conducted by ImmunoSite Technologies aims at identifying a methodology and adequate instrumentation to improve the quality and the throughput of the preservation process.
In this white paper, you will learn about:
- New methods to improve cryopreservation of PBMC to obtain more reliable information from clinical trials
- Previous options and the impact of these procedures on cell quality
- Evaluation criteria and results
- Benefits of using a stable, uniform temperature control solution